Tapewire

Nasdaq · USD

REGN

REGENERON PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
2010
SEC CIK
0000872589
Parsed reports
687

Last 12 months

Inside the activity.

0 purchase rows · 78 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202601
Feb 2026035
Mar 2026013
Apr 202609
May 2026012
Jun 202600
Jul 202601
Aug 202602
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2019 Filed Jan 4, 2019 21:05 UTC GrantCommon Stock 323 $0.00 $0.00
Disclosure

SEC source: 0001708138-19-000006 · edgardoc.xml · nonDerivative · entry 1

Zoghbi Huda Y · CIK 0001681643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:13 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 3,784 $0.00 Strike: $371.40 $0.00
Disclosure

SEC source: 0001237899-19-000006 · edgardoc.xml · derivative · entry 4

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,784

Underlying: Common Stock · 3,784 shares

Expires 2029-01-02

F3 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:13 UTC GrantCommon Stock 323 $0.00 $0.00
Disclosure

SEC source: 0001237899-19-000006 · edgardoc.xml · nonDerivative · entry 1

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:12 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 3,784 $0.00 Strike: $371.40 $0.00
Disclosure

SEC source: 0001237899-19-000004 · edgardoc.xml · derivative · entry 5

SING GEORGE L · CIK 0001225471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,784

Underlying: Common Stock · 3,784 shares

Expires 2029-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:12 UTC GrantCommon Stock 323 $0.00 $0.00
Disclosure

SEC source: 0001237899-19-000004 · edgardoc.xml · nonDerivative · entry 1

SING GEORGE L · CIK 0001225471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,095

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:13 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 3,784 $0.00 Strike: $371.40 $0.00
Disclosure

SEC source: 0001237899-19-000005 · edgardoc.xml · derivative · entry 2

POON CHRISTINE A · CIK 0001189014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,784

Underlying: Common Stock · 3,784 shares

Expires 2029-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:13 UTC GrantCommon Stock 323 $0.00 $0.00
Disclosure

SEC source: 0001237899-19-000005 · edgardoc.xml · nonDerivative · entry 1

POON CHRISTINE A · CIK 0001189014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,113

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:09 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 3,784 $0.00 Strike: $371.40 $0.00
Disclosure

SEC source: 0001237899-19-000003 · edgardoc.xml · derivative · entry 2

GOLDSTEIN JOSEPH L · CIK 0001225474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,784

Underlying: Common Stock · 3,784 shares

Expires 2029-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:09 UTC GrantCommon Stock 323 $0.00 $0.00
Disclosure

SEC source: 0001237899-19-000003 · edgardoc.xml · nonDerivative · entry 1

GOLDSTEIN JOSEPH L · CIK 0001225474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,323

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:08 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 3,784 $0.00 Strike: $371.40 $0.00
Disclosure

SEC source: 0001237899-19-000002 · edgardoc.xml · derivative · entry 2

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,784

Underlying: Common Stock · 3,784 shares

Expires 2029-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:08 UTC GrantCommon Stock 323 $0.00 $0.00
Disclosure

SEC source: 0001237899-19-000002 · edgardoc.xml · nonDerivative · entry 1

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:07 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 3,784 $0.00 Strike: $371.40 $0.00
Disclosure

SEC source: 0001237899-19-000001 · edgardoc.xml · derivative · entry 4

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,784

Underlying: Common Stock · 3,784 shares

Expires 2029-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:07 UTC GrantCommon Stock 323 $0.00 $0.00
Disclosure

SEC source: 0001237899-19-000001 · edgardoc.xml · nonDerivative · entry 3

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,823

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:04 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 3,784 $0.00 Strike: $371.40 $0.00
Disclosure

SEC source: 0001708138-19-000005 · edgardoc.xml · derivative · entry 2

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,784

Underlying: Common Stock · 3,784 shares

Expires 2029-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:04 UTC GrantCommon Stock 323 $0.00 $0.00
Disclosure

SEC source: 0001708138-19-000005 · edgardoc.xml · nonDerivative · entry 1

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:03 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 3,784 $0.00 Strike: $371.40 $0.00
Disclosure

SEC source: 0001708138-19-000004 · edgardoc.xml · derivative · entry 2

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,784

Underlying: Common Stock · 3,784 shares

Expires 2029-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:03 UTC GrantCommon Stock 323 $0.00 $0.00
Disclosure

SEC source: 0001708138-19-000004 · edgardoc.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,510

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
December 20, 2018 Filed Dec 20, 2018 22:36 UTC Exercise / conversionIncentive Stock Option (right to buy) · Derivative 675 $0.00 Strike: $21.25 $0.00
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · derivative · entry 16

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

Underlying: Common Stock · 675 shares

Expires 2019-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 20, 2018 Filed Dec 20, 2018 22:36 UTC SaleCommon Stock 200 $362.45 $72,490.00
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · nonDerivative · entry 11

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,096

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F7 · price: Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $362.02 to $362.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.

Read SEC document
December 20, 2018 Filed Dec 20, 2018 22:36 UTC SaleCommon Stock 100 $361.65 $36,165.00
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · nonDerivative · entry 10

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,296

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 20, 2018 Filed Dec 20, 2018 22:36 UTC SaleCommon Stock 500 $360.40 $180,200.00
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · nonDerivative · entry 9

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,396

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F6 · price: Represents volume-weighted average price of sales of 500 shares of Company stock on December 20, 2018 at prices ranging from $360.18 to $360.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.

Read SEC document
December 20, 2018 Filed Dec 20, 2018 22:36 UTC SaleCommon Stock 200 $359.38 $71,876.00
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · nonDerivative · entry 8

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,896

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F5 · price: Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $359.18 to $359.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 2018 at each separate price.

Read SEC document
December 20, 2018 Filed Dec 20, 2018 22:36 UTC SaleCommon Stock 200 $358.27 $71,654.00
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · nonDerivative · entry 7

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,096

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F4 · price: Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $358.18 to $358.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.

Read SEC document
December 20, 2018 Filed Dec 20, 2018 22:36 UTC SaleCommon Stock 200 $357.50 $71,500.00
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · nonDerivative · entry 6

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,296

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3 · price: Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $357.15 to $357.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.

Read SEC document
December 20, 2018 Filed Dec 20, 2018 22:36 UTC SaleCommon Stock 348 $356.27 $123,981.96
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · nonDerivative · entry 5

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,496

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · price: Represents volume-weighted average price of sales of 348 shares of Company stock on December 20, 2018 at prices ranging from $356.22 to $356.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.

Read SEC document
December 20, 2018 Filed Dec 20, 2018 22:36 UTC SaleCommon Stock 100 $355.14 $35,514.00
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · nonDerivative · entry 4

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,844

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 20, 2018 Filed Dec 20, 2018 22:36 UTC Exercise / conversionCommon Stock 675 $21.25 $14,343.75
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · nonDerivative · entry 3

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,944

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 19, 2018 Filed Dec 20, 2018 22:36 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 3,450 $0.00 Strike: $52.03 $0.00
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · derivative · entry 17

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,326

Underlying: Common Stock · 3,450 shares

Expires 2021-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F9 · derivative.exercise_date: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 19, 2018 Filed Dec 20, 2018 22:36 UTC Tax withholdingCommon Stock 1,602 $364.42 $583,800.84
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · nonDerivative · entry 2

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,269

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 19, 2018 Filed Dec 20, 2018 22:36 UTC Exercise / conversionCommon Stock 3,450 $52.03 $179,503.50
Disclosure

SEC source: 0001237899-18-000026 · edgardoc.xml · nonDerivative · entry 1

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,871

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:19 UTC
SCHLEIFER LEONARD SDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 125,000 $0.00 Strike: $16.80 $0.00
Disclosure

SEC source: 0001237899-18-000022 · edgardoc.xml · derivative · entry 7

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 125,000 shares

Expires 2018-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · derivative.exercise_date: With respect to 187,500 underlying shares, the option became exercisable on December 31, 2011, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2011. With respect to 125,000 underlying shares, the stock option award vested in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:19 UTC
SCHLEIFER LEONARD SDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 187,500 $0.00 Strike: $16.80 $0.00
Disclosure

SEC source: 0001237899-18-000022 · edgardoc.xml · derivative · entry 6

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 187,500 shares

Expires 2018-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · derivative.exercise_date: With respect to 187,500 underlying shares, the option became exercisable on December 31, 2011, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2011. With respect to 125,000 underlying shares, the stock option award vested in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:19 UTC
SCHLEIFER LEONARD SDirector · President & CEO
Tax withholdingCommon Stock 64,052 $377.31 $24,167,460.12
Disclosure

SEC source: 0001237899-18-000022 · edgardoc.xml · nonDerivative · entry 4

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 423,962

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:19 UTC
SCHLEIFER LEONARD SDirector · President & CEO
Exercise / conversionCommon Stock 125,000 $16.80 $2,100,000.00
Disclosure

SEC source: 0001237899-18-000022 · edgardoc.xml · nonDerivative · entry 3

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 488,014

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:19 UTC
SCHLEIFER LEONARD SDirector · President & CEO
Tax withholdingCommon Stock 96,079 $377.31 $36,251,567.49
Disclosure

SEC source: 0001237899-18-000022 · edgardoc.xml · nonDerivative · entry 2

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 363,014

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:19 UTC
SCHLEIFER LEONARD SDirector · President & CEO
Exercise / conversionCommon Stock 187,500 $16.80 $3,150,000.00
Disclosure

SEC source: 0001237899-18-000022 · edgardoc.xml · nonDerivative · entry 1

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 459,093

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 13, 2018 Filed Dec 17, 2018 21:02 UTC
YANCOPOULOS GEORGEDirector · President and Chief Scientific
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 94,048 $0.00 Strike: $16.80 $0.00
Disclosure

SEC source: 0001237899-18-000024 · edgardoc.xml · derivative · entry 11

YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 94,048 shares

Expires 2018-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · derivative.exercise_date: With respect to 150,000 underlying shares, the option became exercisable on December 31, 2011, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2011. With respect to 94,048 underlying shares, the stock option award (combined incentive stock option and non-qualified stock option) vested in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 13, 2018 Filed Dec 17, 2018 21:02 UTC
YANCOPOULOS GEORGEDirector · President and Chief Scientific
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 150,000 $0.00 Strike: $16.80 $0.00
Disclosure

SEC source: 0001237899-18-000024 · edgardoc.xml · derivative · entry 10

YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,048

Underlying: Common Stock · 150,000 shares

Expires 2018-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · derivative.exercise_date: With respect to 150,000 underlying shares, the option became exercisable on December 31, 2011, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2011. With respect to 94,048 underlying shares, the stock option award (combined incentive stock option and non-qualified stock option) vested in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 13, 2018 Filed Dec 17, 2018 21:02 UTC
YANCOPOULOS GEORGEDirector · President and Chief Scientific
GiftCommon Stock 118,993 $0.00 $0.00
Disclosure

SEC source: 0001237899-18-000024 · edgardoc.xml · nonDerivative · entry 6

YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 602,594

Read SEC document
December 13, 2018 Filed Dec 17, 2018 21:02 UTC
YANCOPOULOS GEORGEDirector · President and Chief Scientific
GiftCommon Stock 118,993 $0.00 $0.00
Disclosure

SEC source: 0001237899-18-000024 · edgardoc.xml · nonDerivative · entry 5

YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
December 13, 2018 Filed Dec 17, 2018 21:02 UTC
YANCOPOULOS GEORGEDirector · President and Chief Scientific
Tax withholdingCommon Stock 48,192 $377.31 $18,183,323.52
Disclosure

SEC source: 0001237899-18-000024 · edgardoc.xml · nonDerivative · entry 4

YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,993

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 13, 2018 Filed Dec 17, 2018 21:02 UTC
YANCOPOULOS GEORGEDirector · President and Chief Scientific
Exercise / conversionCommon Stock 94,048 $16.80 $1,580,006.40
Disclosure

SEC source: 0001237899-18-000024 · edgardoc.xml · nonDerivative · entry 3

YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,185

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 13, 2018 Filed Dec 17, 2018 21:02 UTC
YANCOPOULOS GEORGEDirector · President and Chief Scientific
Tax withholdingCommon Stock 76,863 $377.31 $29,001,178.53
Disclosure

SEC source: 0001237899-18-000024 · edgardoc.xml · nonDerivative · entry 2

YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,137

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 13, 2018 Filed Dec 17, 2018 21:02 UTC
YANCOPOULOS GEORGEDirector · President and Chief Scientific
Exercise / conversionCommon Stock 150,000 $16.80 $2,520,000.00
Disclosure

SEC source: 0001237899-18-000024 · edgardoc.xml · nonDerivative · entry 1

YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 12, 2018 Filed Dec 14, 2018 21:49 UTC
VAGELOS P ROYDirector · Chairman of the Board
GrantNon-Qualified Stock Option (right to buy) · Derivative 36,273 $0.00 Strike: $381.40 $0.00
Disclosure

SEC source: 0001237899-18-000023 · edgardoc.xml · derivative · entry 9

VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,273

Underlying: Common Stock · 36,273 shares

Expires 2028-12-12

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 12, 2018 Filed Dec 14, 2018 21:49 UTC
VAGELOS P ROYDirector · Chairman of the Board
SaleCommon Stock 6 $382.32 $2,293.92
Disclosure

SEC source: 0001237899-18-000023 · edgardoc.xml · nonDerivative · entry 5

VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401(k) Plan

Disclosed balance after: 2,304

Read SEC document
December 12, 2018 Filed Dec 14, 2018 21:21 UTC
YANCOPOULOS GEORGEDirector · President and CSO
GrantNon-Qualified Stock Option (right to buy) · Derivative 129,013 $0.00 Strike: $381.40 $0.00
Disclosure

SEC source: 0001104659-18-073103 · a4.xml · derivative · entry 27

YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,013

Underlying: Common Stock · 129,013 shares

Expires 2028-12-12

F1 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 12, 2018 Filed Dec 14, 2018 21:19 UTC
SCHLEIFER LEONARD SDirector · President & CEO
GrantNon-Qualified Stock Option (right to buy) · Derivative 129,013 $0.00 Strike: $381.40 $0.00
Disclosure

SEC source: 0001237899-18-000022 · edgardoc.xml · derivative · entry 8

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,013

Underlying: Common Stock · 129,013 shares

Expires 2028-12-12

F3 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 12, 2018 Filed Dec 14, 2018 21:18 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 11,400 $0.00 Strike: $381.40 $0.00
Disclosure

SEC source: 0001237899-18-000021 · edgardoc.xml · derivative · entry 8

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,400

Underlying: Common Stock · 11,400 shares

Expires 2028-12-12

F3 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 12, 2018 Filed Dec 14, 2018 21:18 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001237899-18-000021 · edgardoc.xml · nonDerivative · entry 2

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,421

F1 · kind: Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 12, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.